SpringWorks Therapeutics Announces European Medicines Agency Validation For Marketing Authorization Application Of Nirogacestat For Treatment Of Adults With Desmoid Tumors
SpringWorks Therapeutics宣布欧洲药品管理局对用于治疗成年硬组织肿瘤的Nirogacestat的上市许可申请进行验证
SpringWorks Therapeutics Announces European Medicines Agency Validation For Marketing Authorization Application Of Nirogacestat For Treatment Of Adults With Desmoid Tumors
SpringWorks Therapeutics宣布欧洲药品管理局对用于治疗成年硬组织肿瘤的Nirogacestat的上市许可申请进行验证
使用浏览器的分享功能,分享给你的好友吧